EUVIMEDEUVIMED entdecken
Crossref

Prognostic value of pretherapeutic 68Ga-PSMA-11-PET based imaging parameters in mCRPC patients treated with PSMA radioligands

Laya Rahbar Nikoukar, Robert Seifert, David Ventura, Philipp Schindler, Martin Bögemann, Kambiz Rahbar, Wolfgang Roll

Nuklearmedizin - NuclearMedicine · 01.03.2025 · 64 (01) · 7-12

DOI: 10.1055/a-2383-2468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.03.2025. Verfasst von Laya Rahbar Nikoukar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Nuclear Medicine, University Hospital Münster, Münster, Germany. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Positron-Emission Tomography, Edetic Acid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to evaluate the prognostic significance of various previously reported PSMA-PET parameters in patients undergoing 177Lu-PSMA radioligand therapy (RLT). While individual studies have investigated the prognostic value of one or few of these factors, comprehensive analyses are rare. Data of 82 patients undergoing 177Lu-PSMA-radiologand-therapy (RLT) were analyzed. Total tumor volume (tumor volume), average SUVmean of all tumor lesions (SUVmean) and the quotient of sum of SUVmean of all tumor lesions to SUVmean of the parotid glands (tumor-parotid-ratio; TPR) and of the kidneys (tumor-kidney-ratio; TKR) were included in analysis. This study showed that a tumor volume of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic Neoplasms, Castration-ResistantPositron-Emission TomographyEdetic AcidHumansMalePrognosisAgedMiddle AgedGallium IsotopesGallium RadioisotopesRadiopharmaceuticalsAged, 80 and overTreatment OutcomeLutetium

Substanzen

gallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesRadiopharmaceuticalsLutetiumEdetic Acid

Autor:innen und Institutionen

  • Clinic for Nuclear Medicine, University Hospital Münster, Münster, Germany.
  • 2. West German Cancer Center (WTZ), Münster site, Germany, Münster, Germany.
  • Radiology, University Hospital Münster, Münster, Germany.
  • Clinic for Urology, University Hospital Münster, Münster, Germany.
  • West German Cancer Center (WTZ), Münster site, Germany, Münster, Germany.

Zitieren

APA

Rahbar Nikoukar, L., Seifert, R., Ventura, D., Schindler, P., Bögemann, M., Rahbar, K., & Roll, W. (2025). Prognostic value of pretherapeutic 68Ga-PSMA-11-PET based imaging parameters in mCRPC patients treated with PSMA radioligands. Nuklearmedizin - NuclearMedicine, 64(01), 7-12. https://doi.org/10.1055/a-2383-2468

Vancouver

Rahbar Nikoukar L, Seifert R, Ventura D, Schindler P, Bögemann M, Rahbar K, et al. Prognostic value of pretherapeutic 68Ga-PSMA-11-PET based imaging parameters in mCRPC patients treated with PSMA radioligands. Nuklearmedizin - NuclearMedicine. 2025;64(01):7-12. doi:10.1055/a-2383-2468

BibTeX
@article{RahbarNikoukar2025,
  author = {Rahbar Nikoukar, Laya and Seifert, Robert and Ventura, David and Schindler, Philipp and Bögemann, Martin and Rahbar, Kambiz and Roll, Wolfgang},
  title = {Prognostic value of pretherapeutic 68Ga-PSMA-11-PET based imaging parameters in mCRPC patients treated with PSMA radioligands},
  journal = {Nuklearmedizin - NuclearMedicine},
  year = {2025},
  volume = {64},
  number = {01},
  pages = {7--12},
  doi = {10.1055/a-2383-2468}
}
Kostenlos starten →